The effect of emicizumab prophylaxis on health ‐related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study

ConclusionsIn PwHA with inhibitors, emicizumab prophylaxis was associated with substantial and meaningful improvements in health ‐related outcomes.

Source: Haemophilia - November 14, 2018 Category: Hematology Authors: Johannes Oldenburg, Johnny N. Mahlangu, Willem Bujan, Peter Trask, Michael U. Callaghan, Guy Young, Elina Asikanius, Flora Peyvandi, Elena Santagostino, Rebecca Kruse ‐Jarres, Claude Negrier, Craig Kessler, Jin Xu, Jerzy Windyga, Midori Sh Tags: ORIGINAL ARTICLE Source Type: research